Literature DB >> 29344094

Robotic prostatectomy leading to a delayed MRSA infected lymphocele: a case report and review of the literature.

Monica Kaminski1, Rose Recco2, Steven Siegel3.   

Abstract

Prostate cancer is the second leading cancer-related cause of death in the USA with the majority presenting as localized disease. In the last decade minimally invasive, robotic-assisted laparascopic, radical prostatectomy has become the most favored treatment choice. A complication that has been observed in 27% of patients is the formation of an asymptomatic lymphocele. It is a very rare complication for these to become infected, and when they do 80% have occurred 2-12 months post-procedure. In this case report the patient presented with fever and leukocytosis of unknown origin and was found to have a methicillin-resistant Staphylococcus aureus (MRSA) infected lymphocele over 2 years after a radical prostatectomy. The infected fluid collection was drained percutaneously and the patient was treated with a 4-week course of intravenous ceftaroline with complete resolution of symptoms.

Entities:  

Keywords:  MRSA; ceftaroline; lymphocele; robotic prostatectomy

Year:  2017        PMID: 29344094      PMCID: PMC5761915          DOI: 10.1177/1756287217735798

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  13 in total

1.  Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.

Authors:  Karissa Jongsma; Jeremiah Joson; Arash Heidari
Journal:  J Antimicrob Chemother       Date:  2013-01-22       Impact factor: 5.790

Review 2.  How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy.

Authors:  Hak J Lee; Christopher J Kane
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

3.  Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases.

Authors:  Mathias Tremp; Tullio Sulser; Hans-Helge Seifert
Journal:  Urol Int       Date:  2009-12-08       Impact factor: 2.089

4.  Delayed infection of a pelvic lymphocele following pelvic lymphadenectomy.

Authors:  J M Carbone; R B Nadler; A D Bullock; J W Basler
Journal:  Urology       Date:  1996-01       Impact factor: 2.649

5.  Ultrasonic evaluation of lymphocele formation after staging lymphadenectomy for prostatic carcinoma.

Authors:  D B Spring; D Schroeder; S Babu; R Agee; G A Gooding
Journal:  Radiology       Date:  1981-11       Impact factor: 11.105

Review 6.  Robotic-Assisted Laparoscopic Radical Prostatectomy.

Authors:  Gautum Agarwal; Oscar Valderrama; Adam M Luchey; Julio M Pow-Sang
Journal:  Cancer Control       Date:  2015-07       Impact factor: 3.302

7.  Surgical complications associated with robotic urologic procedures in elderly patients.

Authors:  Antonio Cusano; Peter Haddock; Ilene Staff; Max Jackson; Fernando Abarzua-Cabezas; Ryan Dorin; Anoop Meraney; Joseph Wagner; Steven Shichman; Stuart Kesler
Journal:  Can J Urol       Date:  2015-02       Impact factor: 1.344

8.  Preventing perioperative complications of robotic-assisted radical prostatectomy.

Authors:  Michael A Liss; Douglas Skarecky; Blanca Morales; Kathryn Osann; Louis Eichel; Thomas E Ahlering
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

Review 9.  Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; William A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Pharmacotherapy       Date:  2009-11       Impact factor: 4.705

10.  Management of pelvic lymphoceles after radical prostatectomy: a multicentre community based study.

Authors:  W Y Khoder; M Trottmann; M Seitz; A Buchner; A Stuber; S Hoffmann; C G Stief; A J Becker
Journal:  Eur J Med Res       Date:  2011-06-21       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.